How Much Did Pathology Reference Laboratory Raise?
Funding & Key Investors

Pathology Reference Laboratory has solidified its position within the clinical diagnostics sector, securing a total capital infusion of $2.8M. This trajectory of financial backing, highlighted by a recent strategic investment of $1.8M, underscores the firm's critical role in supporting hospital networks and physician practices. By leveraging these resources, the organization continues to scale its diagnostic capabilities, ensuring that its century-long commitment to medical excellence remains aligned with modern healthcare demands.

The firm's ability to attract significant debt financing reflects a robust operational model and a stable market presence. As the healthcare landscape shifts toward more complex molecular diagnostics, this influx of capital provides the necessary liquidity to maintain high-throughput testing environments while upholding rigorous quality standards across its diverse subspecialty departments.